- Title:
Change of Nominated Adviser and Broker - Time:
07:00:08 - Date:
12 Jan 2021 - Category:
Corporate updates - ID:
3192L
Circassia Group plc
Change of Nominated Adviser and Broker
Oxford, UK - 12 January 2021: Circassia Group plc ("Circassia" or "the Company") (LSE: CIR), a medical device company focused on respiratory diagnostics and monitoring, today announces that N+1 Singer has been appointed as the Company's nominated adviser and sole broker with immediate effect.
-Ends-
For further information, please contact:
| Circassia Ian Johnson, Executive Chairman Michael Roller, Chief Financial Officer Sarah Duncan, Company Secretary
|
|
Tel: +44(0)1865 405566 |
| N+1 Singer (Nominated Adviser and Broker) Aubrey Powell / Jen Boorer / Hannah Woodley
|
|
Tel: +44 (0) 20 7496 3000 |
Change of Nominated Adviser and Broker07:00:0812 Jan 2021Corporate updates3192L